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Elimination of lymphoid tissue reservoirs is a key
component of HIV eradication strategies. CD8+
T cells play a critical role in control of HIV, but their
functional attributes in lymph nodes (LNs) remain
unclear. Here, we show that memory, follicular
CXCR5+, and HIV-specific CD8+ T cells from LNs
do not manifest the properties of cytolytic CD8+
T cells. While the frequency of follicular CXCR5+
CD8+ T cells was strongly inversely associated with
peripheral viremia, this association was not depen-
dent on cytolytic CXCR5+ CD8+ T cells. Moreover,
the poor cytolytic activity of LN CD8+ T cells was
linked to a compartmentalized dissociation between
effector programming and the transcription factor
T-bet. In line with this, activation of LN CD8+ T cells
only partially induced the acquisition of cytolytic
functions relative to peripheral blood CD8+ T cells.
These results suggest that a state of immune privi-
lege against CD8+ T cell-mediated cytolysis exists
in lymphoid tissue, potentially facilitating the persis-
tence of HIV.
INTRODUCTION
Elimination of viral reservoirs is a major obstacle to the eradica-
tion of HIV (Chun et al., 2015). One such reservoir, the lymph
node (LN)-resident CD4+ T follicular helper cell (Tfh) compart-
ment, is a major site of ongoing viral replication (Banga et al.,
2016; Lindqvist et al., 2012; Perreau et al., 2013; Petrovas3458 Cell Reports 21, 3458–3470, December 19, 2017 ª 2017 The A
This is an open access article under the CC BY-NC-ND license (http://et al., 2012). It is established that cytolytic CD8+ T cells are
required for effective immune control of HIV and simian immu-
nodeficiency virus (SIV) (Fukazawa et al., 2015; Koup et al.,
1994; Schmitz et al., 1999). However, the mechanisms of
CD8+ T cell immunosurveillance within lymphoid tissue are not
well defined. HIV/SIV-specific CD8+ T cells have been identified
in LNs but rarely within the B cell follicles (Chun et al., 2015;
Connick et al., 2007, 2014; Folkvord et al., 2005; Oxenius
et al., 2001). Recent studies also suggest that LN CD8+
T cells control SIV replication in extra-follicular CD4+ T cells,
but not in follicular CD4+ T cells (Fukazawa et al., 2015; Lindqv-
ist et al., 2012; Perreau et al., 2013; Petrovas et al., 2012, 2017).
Accordingly, HIV-infected CD4+ Tfh cells are thought to evade
immune surveillance largely via segregation from cytolytic
CD8+ T cells.
Much of what is known about human CD8+ T cell cytolytic
function, phenotype, and transcriptional regulation derives
from studies of peripheral blood. In the context of HIV infection,
clear associations have been demonstrated between control of
HIV and HIV-specific CD8+ T cell cytolytic function, as measured
by expression of cytolytic molecules, direct cytolytic killing
capacity, and/or expression of the canonical effector function
transcription factor T-bet, and control of HIV (Hersperger et al.,
2010, 2011b; Migueles et al., 2002, 2008; Sa´ez-Cirio´n et al.,
2007). However, it is unclear whether CD8+ T cell cytolytic func-
tion is manifest in HIV-infected lymphoid tissue. Intuitively, the
presence of cytolytic CD8+ T cells in LNs, critical sites of antigen
presentation and B/T cell priming, seems counterproductive for
the generation and maintenance of immune responses. A num-
ber of studies in humans and mice have indeed suggested that
CD8+ T cells in lymphoid tissue have limited cytolytic capacity
(Andersson et al., 1999; Jo¨hrens et al., 2006; Quigley et al.,
2007; Wolint et al., 2004; Yang et al., 2005). Nonetheless, authors.
creativecommons.org/licenses/by-nc-nd/4.0/).
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.systematic evaluation of perforin and granzyme B expression,
linked with the regulatory elements T-bet and eomesodermin,
has not been reported previously for LN CD8+ T cells.
Here, we examined the expression of cytolytic proteins and
their underlying regulatory elements in total, follicular, and HIV-
specific CD8+ T cells in LNs. We find that CD8+ T cells in HIV-
infected lymphoid tissue, regardless of follicular localization,
display low-level, discordant, and dysregulated expression of
perforin and granzyme B. These results suggest that the failure
of CD8+ T cells to eliminate HIV-infected CD4+ T cells is related
not only to physical segregation from infected CD4+ Tfh cells in
lymphoid follicles but also to a generalized state of functional
immune privilege against cytolytic activity in lymphoid tissue.
These findings have broad implications for cure and eradication
strategies designed to invoke CD8+ T cell-mediated clearance of
HIV-infected CD4+ T cells.
RESULTS
Characteristics of Memory and Cytolytic CD8+ T Cells in
HIV-Infected LNs
To define the phenotypic, functional, and cytolytic properties
of LN CD8+ T cells, we obtained LNs and peripheral blood
mononuclear cells (PBMCs) from HIV, chronically infected
HIV+, and HIV+ individuals on antiretroviral therapy (ART;
Table 1). We found significantly fewer memory CD8+ T cells
within LNs compared to blood regardless of HIV infection status.
However, HIV-infected individuals had expanded memory CD8+
T cells in blood and LNs (Figure S1A). HIV-infected LNs had
increased frequencies of effector memory (CD27 CD45RO+)
CD8+ T cells compared to HIV subjects (Figure 1A), but unlike
PBMCs, LNs contained few terminally differentiated effector
(CD27 CD45RO) CD8+ T cells (Figure 1A).
Given the low abundance of effector CD8+ T cells in LNs (Fig-
ure 1A), we assessed perforin and granzyme B (gzmB) expres-
sion, each linked to control of HIV disease progression (Her-
sperger et al., 2011b). Compared to peripheral blood, fewer LN
CD8+ T cells expressed perforin in HIV individuals and treated
and untreated HIV+ individuals (p < 0.001, Figure 1B). More
LN memory CD8+ T cells expressed perforin during chronic
and ART-treated HIV infection compared to HIV individuals
(p < 0.001 and p < 0.05, respectively). However, LN memory
CD8+ T cells expressed less perforin per cell than PBMCs
(p < 0.001; Figure 1B). Similar trends were observed for gzmB
(Figure 1C; data not shown). Consistent with previous reports
(Chattopadhyay et al., 2009; Hersperger et al., 2011a; Makedo-
nas et al., 2010), perforin and gzmB were co-expressed in blood
memory CD8+ T cells (Figure 1C) but notably dissociated in LN
memory CD8+ T cells (Figure 1C). This dissociation was some-
what mitigated in chronic HIV infection but remained evident in
lymphoid tissue across all subjects. Unbiased computational
t-distributed stochastic neighbor embedding (tSNE) analysis
(Shekhar et al., 2014) of all collected parameters on memory
PBMCs and LN mononuclear cells (LNMCs) in both HIV and
treated and untreated HIV+ individuals further highlighted the
dissociated nature of perforin and gzmB expression within LN
memory CD8+ T cells and lack of the effector perforin+ popula-
tion found in blood (Figures 1D and S1E).Cell Reports 21, 3458–3470, December 19, 2017 3459
Figure 1. HIV Infection Induces Accumulation of Effector Memory CD8+ T Cells with Low Levels of Perforin Expression in LNs
(A) Representative flow plots (left) showing CD3+ CD8+ T cells in PBMCs (top) and LNMCs (bottom) from a chronically infected HIV+ individual, and a comparison
of memory subsets (right) in PBMCs versus LNMCs.
(B) Representative flow plots (left) showing memory CD8+ T cell expression of perforin in PBMCs (top row) versus LNMCs (bottom row) from an HIV individual
versus a chronically infected HIV+ individual. Perforin frequency andMFI in memory CD8+ T cells in PBMCs versus LNMCs is shown on the right for HIV, chronic
HIV+, and ART-treated HIV+ individuals.
(legend continued on next page)
3460 Cell Reports 21, 3458–3470, December 19, 2017
Cytolytic Properties of CXCR5+ LN Follicular CD8+ T
Cells Are Not Associated with Control of Viremia
Recent studies suggest that follicular CXCR5+ CD8+ T cells are
involved in the control of chronic viral infections (He et al.,
2016; Im et al., 2016; Leong et al., 2016; Mylvaganam et al.,
2017; Petrovas et al., 2017). We therefore assessed whether
the CXCR5+ CD8+ T cell population in HIV-infected LNs was
present and linked to viremic control. A similar proportion
(20%) of LN memory CD8+ T cells expressed CXCR5 in HIV+
and HIV individuals (Figure 2A). We found a strong inverse
correlation between the frequency of LN CXCR5+ CD8+ T cells
and viral load (Figure 2B), suggesting an association with control
of HIV. We therefore explored whether CXCR5+ follicular CD8+
T cells expressed perforin and gzmB.
Similar to CXCR5 CD8+ T cells, the majority of CXCR5+
CD8+ T cells in HIV LNs did not express perforin (Figure 2C).
The frequency of perforin-expressing cells was elevated in
both CXCR5+ and CXCR5 memory CD8+ T cells in HIV-
infected LNs regardless of treatment status (Figure 2C), with
CXCR5+ CD8+ T cells being slightly more likely to express per-
forin. However, the overall frequency of perforin+ cells was still
low compared to peripheral memory CD8+ T cells (Figures 1B
and 2C), and the low amount of perforin on a per-cell basis
did not differ based on CXCR5 expression or HIV infection sta-
tus (Figure S1B). Further, to determine whether CXCR5+ CD8+
T cells had a differential ability to kill targets compared to
CXCR5 CD8+ T cells, we performed a redirected cell lysis
assay (adapted from Kiniry et al., 2017) measuring induction
of active caspase-3 using as effector cells CXCR5+ and
CXCR5 CD8+ T cells isolated from HIV-infected tonsils (Fig-
ure 2D). While CD8+ T cells from control HIV+ PBMCs demon-
strated a strong induction of active caspase-3, tonsillar
CXCR5+ CD8+ T cells had very little killing ability in comparison.
Moreover, contrary to recent reports (Petrovas et al., 2017), we
did not find that CXCR5+ CD8+ T cells exhibited stronger cyto-
lytic activity than CXCR5 CD8+ T cells. Similar to memory
CD8+ T cells, CXCR5+ CD8+ T cells displayed dissociated per-
forin and gzmB co-expression patterns (Figure 2E). Unbiased
tSNE analysis showed a similar dissociation trend between
perforin and gzmB co-expression (Figure 2F). To confirm
whether cytolytic molecule expression patterns in CXCR5+
CD8+ T cells matched those physically located in B cell follicles,
we performed multispectral confocal imaging analysis. CD8+
T cells within B cell follicles of HIV individuals rarely expressed
perforin and gzmB (Figure S1C). In HIV-infected LNs, irrespec-
tive of treatment status, a higher frequency of follicular CD8+
T cells expressed perforin or gzmB (Figures 2G and S1C), but
only a small fraction co-expressed both proteins (Figure S1D).(C) Representative flow plots (left) showing perforin versus gzmB expression in P
frequency of perforin co-expression in gzmB+ memory CD8+ T cells (right) in PB
(D) Cell ACCENSE tSNE plots of perforin and gzmB expression in memory CD8+ T
on n = 4/group). The highlighted area in lower right of each tSNE plot represents
The statistical tests usedwere the Kruskal-Wallis test with Dunn’s post-test (for be
within a subject group between tissue compartments), and the Wilcoxon matche
Blue circle, open blue circle, HIV; black square, open black square, HIV+ therap
represent mean ± SEM. In all figures, closed symbols represent PBMCs and ope
CD45RO expression patterns.In contrast to the inverse association between the frequency
of LN CXCR5+ CD8+ T cells and viral load (Figure 2B), we found
no association between the frequency of perforin-expressing
LN CXCR5+ CD8+ T cells and viral load (Figure 2H). Together,
these data suggest that while follicular CXCR5+ CD8+ T cells
may be a component of viral control, cytolytic properties are
unlikely to be the mechanism by which follicular CD8+ T cells
impact peripheral viremia.
Dissociation between Cytolytic CD8+ T Cells and T-Box-
Binding Transcription Factors in LNs
We next addressed the potential mechanisms underlying the
differential cytolytic properties of LNs and peripheral blood
CD8+ T cells. The transcription factors T-bet and eomesodermin
(eomes) regulate effector differentiation and cytolytic function in
peripheral blood CD8+ T cells (Cruz-Guilloty et al., 2009; Jenner
et al., 2009; Pearce et al., 2003; Pipkin et al., 2010). High levels of
T-bet expression have been associated with cytolytic function in
human CD8+ T cells (Buggert et al., 2014; Hersperger et al.,
2011a). We found that while T-bethigh cells were readily detect-
able in peripheral blood in all subjects tested regardless of
HIV infection status, T-bethigh CD8+ T cells were rare in LNs
(p < 0.001; Figures 3A and S2A). When found,60% of T-bethigh
cells in the LN expressed perforin, substantially lower than in
matched peripheral blood (Figure S2G). Becausewe rarely found
T-bethigh CD8+ T cells in LNs, we focused the remainder of our
analysis on characterizing all T-bet+ cells rather than separating
low versus high expression. As expected, a large proportion of
perforin+ CD8+ T cells in blood co-expressed T-bet, but this as-
sociation was lost in LNCD8+ T cells, especially for HIV+ subjects
(Figures 3A, S2A, and S2B), where perforin+ CD8+ T cells were
less likely to express T-bet. Eomes was expressed in 40% of
blood and LN memory CD8+ T cells regardless of infection or
treatment status (Figure S2A) and was not clearly associated
with perforin expression in either blood or LNCD8+ T cells (Figure
S2C). Similarly, few T-bet+ CD8+ T cells in LNs expressed gzmB
compared to blood (Figures S2D and S2E). We found no clear
association between gzmB expression and eomes in LN or pe-
ripheral blood CD8+ T cells (Figures S2D–S2F). Finally, most
perforin/gzmB+ PBMC CD8+ T cells co-expressed T-bet (Fig-
ure 3B), but this association was again absent for LN perforin/
gzmB+ CD8+ T cells (Figure 3B). We further assessed T-bet
expression in CXCR5+ CD8+ T cells. Memory CXCR5+ and
CXCR5 CD8+ T cells had similarly low expression levels of
T-bet independent of HIV treatment status (Figure 3C). Together,
these data indicate that perforin-expressing memory CD8+
T cells in LNs are transcriptionally and functionally distinct from
peripheral blood CD8+ T cells, especially in HIV-infected LNs.BMCs (top) versus LNMCs (bottom) from an ART-treated HIV+ individual, and
MCs versus LNMCs.
cells comparing PBMCs and LNMCs from ART-treated HIV+ individuals (based
cytolytic effector CD8+ T cells.
tween-subject groups within a tissue compartment), theMann-Whitney test (for
d-pairs two-tailed test (for paired samples). *p < 0.05; **p < 0.01; ***p < 0.001.
y naive; red triangle, open red triangle, HIV+ on ART. Ranges shown on plots
n symbols represent LNMCs. Memory subsets were determined by CD27 and
Cell Reports 21, 3458–3470, December 19, 2017 3461
Figure 2. CXCR5+ CD8+ T Cells Are Associated with Control of HIV Independent of Perforin Expression in LNs
(A) Representative flow plot (left) showing memory CD8+ T cell expression of CXCR5 in LNMCs from a chronically infected HIV+ individual, and frequency of LN
CXCR5+ memory CD8+ T cells (right) in HIV, chronic HIV+, and ART-treated HIV+ individuals.
(B) The frequency of CXCR5+ memory CD8+ T cells in LNMCs is inversely associated with HIV plasma viral load. Statistical significance was determined using
Spearman’s test. Data shown were obtained from untreated HIV+ individuals with chronic infection.
(C) Perforin frequency in CXCR5+ and CXCR5 memory CD8+ T cells in LNMCs.
(D) Redirected killing assaymeasuring the ability of tonsillar CXCR5+ andCXCR5CD8+ T cells isolated from n = 4 donors to kill anti-CD3 coated P815 target cells
using activate caspase-3 as a readout.
(E) Frequency of gzmB co-expression in perforin+ CXCR5+ memory CD8+ T cells in LNMCs.
(F) Cell ACCENSE tSNE plots of perforin and gzmB expression in CXCR5+ memory CD8+ T cells in LNMCs from ART-treated HIV+ individuals (tSNE based on
n = 4).
(legend continued on next page)
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Figure 3. CD8+ T Cells Exhibit Dissociation
between Transcriptional Drivers of Cytolytic
Function and Expression of Cytolytic Pro-
teins in LNs
(A) Representative flow plots (left) showing mem-
ory CD8+ T cell expression of T-bet and perforin in
PBMCs and LNMCs from an ART-treated HIV+
individual, and frequency of T-bethigh memory
CD8+ T cells (right) in PBMCs and LNMCs. T-bet
gating shown is the sum of the upper gates in the
representative flow plots.
(B) T-bet frequency in memory CD8+ T cells ex-
pressing perforin and/or gzmB in PBMCs and
LNMCs.
(C) Representative flow plots (left) showing mem-
ory CD8+ T cell expression of T-bet and CXCR5 in
LNMCs from HIV- and HIV+ chronic, and T-bet
frequency in CXCR5+ and CXCR5 CD8+ T cells
(right) in LNMCs.
Statistical significance between subject groups
within a tissue compartment was determined us-
ing the Kruskal-Wallis test with Dunn’s post-test.
Statistical significance within a subject group
between tissue compartments was determined
using the Mann-Whitney two-tailed test. *p < 0.05;
**p < 0.01; ***p < 0.001. Blue circle, open blue
circle, HIV; black square, open black square,
HIV+ therapy-naive; red triangle, open red triangle,
HIV+ on ART. Ranges shown on plots represent
mean ± SEM.LN HIV-Specific CD8+ T Cells Express Low Levels of
Cytolytic Molecules and T-bet
Most studies to date have characterized bulk or memory CD8+
T cell populations in HIV-infected LNs. However, except for
interferon-g (IFN-g) ELISpot analysis (Altfeld et al., 2002) and
major histocompatibility complex (MHC) class I tetramer quan-
tification (Connick et al., 2007), the functional and phenotypic
properties of HIV-specific CD8+ T cells in LNs remain largely un-
defined. To address this knowledge gap, we screened for im-
munodominant HLA-A*0201-, HLA-A*2402-, and HLA-B*0702-
restricted HIV-specific CD8+ T cell responses in LNs using
MHC class I tetramers. Eight paired HIV MHC class I tetramer
responses were identified in both HIV-infected LNs and blood
from five donors. We found that the frequencies of HIV-specific
CD8+ T cells were largely similar between blood and LNs (Fig-
ure 4A). Overlapping HIV Gag and Env peptide stimulations
confirmed that the frequency of IFN-g+ and/or tumor necrosis
factor (TNF)+ HIV-specific CD8+ T cell responses was compara-(G) IHC staining of paraffin-embedded tissue sections showing CD8+ T cells in B
from a chronically infected HIV+ individual (scale bar, 100 mm). Boxes highlight ar
red, perforin; green, gzmB.
(H) The frequency of perforin-expressing CXCR5+ CD8+ T cells in LNMCs is not
using Spearman’s test. Data shown were obtained from untreated HIV+ individua
Statistical significance between subject groups was determined using the Kruskal
between tissue compartments was determined using the Mann-Whitney two-tail
square, HIV+ therapy naive; open red triangle, HIV+ on ART. Ranges shown on pble between blood and LN irrespective of ART status (Fig-
ure S3A). The memory phenotype of LN HIV-specific CD8+
T cells was largely similar to blood, with the exception that
effector memory HIV-specific CD8+ T cells were more common
in blood compared to LN (Figure 4B). Importantly, LN HIV-spe-
cific CD8+ T cells expressed significantly lower levels of gzmB
and perforin compared to peripheral blood (Figure 4C). Perforin
frequencies (Figure S3B) and median fluorescence intensity
(MFI) values (Figure S3C) in HIV-specific cytokine-producing
CD8+ T cells were similar between chronically infected and
ART-treated HIV+ subjects in both blood and LNs. However,
similar to the HIV-tetramer+ CD8+ T cells, blood HIV-specific
CD8+ T cells producing IFN-g and/or TNF demonstrated
increased frequency (Figure S3B) and MFI (Figure S3C) for per-
forin compared to LN HIV-specific CD8+ T cells. Perforin and
gzmB expression was almost perfectly correlated in blood
HIV-specific CD8+ T cells but completely dissociated in LNs
(Figure 4D).cell follicles. Top row: low-magnification view of a representative B cell follicle
eas for 103 zoom in bottom row (scale bar, 10 mm). Purple, CD19; cyan, CD8;
associated with HIV plasma viral load. Statistical significance was determined
ls with chronic infection.
-Wallis test with Dunn’s post-test. Statistical significancewithin a subject group
ed test. *p < 0.05; **p < 0.01; ***p < 0.001. Open blue circle, HIV; open black
lots represent mean ± SEM.
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Figure 4. HIV-Specific CD8+ T Cells Are Poorly Cytolytic and Express Low Levels of T-Bet and CXCR5 in LNs
(A) Flow plots (left) showing FLGKIWPSHK (FK10)/HLA-A*0201 and ILKEPVHGV (IV9)/HLA-A*0201 tetramer stains of PBMCs and LNMCs from the same subject,
and frequency of matched HIV-tetramer+ CD8+ T cell responses (right) in PBMCs and LNMCs.
(B) Compartmentalization of HIV-tetramer+ CD8+ T cell responses within different memory subsets: central memory (CM; CCR7+ CD27+ CD45RO+), transitional
memory (TM; CCR7 CD27+ CD45RO+), effector memory (EM; CCR7 CD27 CD45RO+), and terminally differentiated (TD; CCR7 CD27 CD45RO).
(C) Flow cytometry plots (left) showing gzmB expression in HIV-tetramer+ CD8+ T cells in PBMCs and LNMCs from the same subject, and frequency of perforin
and gzmB expression for all HIV-tetramer+ CD8+ T cells (right) in PBMCs and LNMCs.
(D) Frequency of perforin and gzmB co-expression in matched HIV-tetramer+ CD8+ T cells (left) in PBMCs (blue) and LNMCs (red), and correlation between
perforin+ and gzmB+ HIV-tetramer+ CD8+ T cells (right) in PBMCs (blue) and LNMCs (red).
(E) Frequency of perforin+ HIV-tetramer+ CD8+ T cells within the T-bethigheomesdim population (left) in PBMCs (blue) and LNMCs (red), and correlation between
perforin+ and HIV-tetramer+ CD8+ T cells (right) in PBMCs (blue) and LNMCs (red).
(F) Flow plots (left) showing HIV-tetramer+ CD8+ T cell expression of CXCR5 and perforin for two distinct specificities in LNMCs from the same subject, frequency of
CXCR5+versusCXCR5HIV-tetramer+CD8+Tcells (middle) inLNMCs,andperforinexpression inCXCR5+andCXCR5HIV-tetramer+CD8+Tcells (right) inLNMCs.
Flow plots are representative of chronically infected HIV+ individuals. Statistical significance within a subject group between tissue compartments was deter-
mined using the Mann-Whitney two-tailed test. Statistical significance for correlations was determined using Spearman’s test. Ranges shown on plots represent
median and interquartile range (IQR).
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We have previously shown that increased effector HIV-
specific CD8+ T cell functions in peripheral blood are closely
related to high expression levels of T-bet and intermediate levels
of eomes (T-bethigheomesdim) (Buggert et al., 2014). In blood, we
found that perforin+ HIV-specific CD8+ T cells were primarily
T-bethigheomesdim, while perforin+ HIV-specific CD8+ T cells in
LN were instead T-betdimeomeshi (Figure 4E). This latter profile
has been associated with exhaustion (Buggert et al., 2014).
As predicted, the frequency of perforin+ HIV-tetramer+ CD8+
T cells in blood was directly associated with a T-bethigheomesdim
phenotype (Figure 4E), but no association was found between
perforin expression and the T-bethieomesdim profile in LN
HIV-specific CD8+ T cells (Figure 4E).
Finally, we addressed whether CXCR5+ HIV-specific CD8+
T cells express cytolytic molecules. Previous immunohisto-
chemistry studies have demonstrated that LN HIV-specific
CD8+ T cells are primarily compartmentalized to the T cell zone
(Connick et al., 2007, 2014). In accordance with these reports,
we found that most LN HIV-tetramer+ (Figure 4F) and cytokine
producing HIV-specific CD8+ T cells were CXCR5 (Figure S3D)
regardless of treatment status. We found no difference in the fre-
quency of perforin expression between CXCR5+ and CXCR5
HIV-tetramer+ CD8+ T cells (Figure 4F). Perforin expression
was also indistinguishable between chronically infected and
ART-treated subjects for CXCR5+ HIV Gag/Env-specific CD8+
T cells (Figure S3E). Together, these data indicate that LN HIV-
specific CD8+ T cells, regardless of their follicular localization,
do not bear the characteristics of peripheral blood cytolytic
CD8+ T cells.
Activation Does Not Fully Restore the Cytolytic
Properties of LN HIV-Specific CD8+ T Cells
To determine whether activated LN CD8+ T cells have or can ac-
quire cytolytic properties, we examinedwhether ex vivo LNCD8+
T cells entering the cell cycle, identified as Ki67+ (Gerdes et al.,
1984), express perforin or gzmB. Similar to blood, LN CD8+
T cells displayed higher levels of Ki67 expression in individuals
with chronic HIV infection than in HIV and ART-treated individ-
uals (Figure S4A). Ki67+ LN memory CD8+ T cells in treated and
untreated HIV+ individuals co-expressed perforin and/or gzmB
more frequently than Ki67+ LN memory CD8+ T cells in HIV in-
dividuals (Figure S4B). However, Ki67 cells in HIV+ individuals
also maintained higher levels of perforin and gzmB expression
than HIV subjects. Ki67+ LN memory CD8+ T cells were not
more likely to express T-bet compared to Ki67 LN memory
CD8+ T cells in any subject group, but eomes trended toward
higher expression in both Ki67+ and Ki67 cells in HIV+ individ-
uals compared to HIV controls (Figures S4D and S4E).
We next performed in vitro carboxyfluorescein succinimidyl
ester (CFSE) assays to determine whether proliferating HIV
Gag/Nef-specific LN CD8+ T cells acquire cytolytic effector
properties. Robust cell division was observed in LN (Figures 5
and S4F) and peripheral blood (Figure S5) CD8+ T cells after
stimulation with HIV Gag/Nef in most HIV-infected donors and
after nonspecific stimulation with staphylococcal enterotoxin B
(SEB) in all donors. While SEB readily induced perforin, gzmB,
and T-bet expression in dividing LN and peripheral blood CD8+
T cells after 1 or 2 cell divisions, dividing HIV-specific CD8+T cells differentially upregulated these proteins. Dividing LN
HIV Gag/Nef-specific CD8+ T cells upregulated perforin and
gzmB (Figures 5A and 5B), but not as rapidly or consistently as
the SEB control (Figure S4G). The amount of perforin on a per
cell basis also remained lower for LNCD8+ T cells than peripheral
blood CD8+ T cells (Figure S5B). In contrast, SEB-stimulated LN
and peripheral blood CD8+ T cells upregulated gzmB similarly
(Figures S4G and S5A). Finally, unlike SEB-stimulated LN CD8+
T cells, LN HIV-specific CD8+ T cells did not strongly upregulate
T-bet (Figure 5C). Together, these results indicate that LN CD8+
T cells can gain some aspects of cytolytic function after activa-
tion but do not under these conditions acquire the cytolytic prop-
erties characteristic of circulating effector CD8+ T cells.
Activated LN CD8+ T Cells Acquire LN Egress/Tissue
Homing Properties but Do Not Acquire LN Follicular
Homing Markers
Induction of effector function in LN CD8+ T cells is associated
with upregulation of LN egress and tissue homing proteins (Cys-
ter and Schwab, 2012; Matloubian et al., 2004; Shiow et al.,
2006; Wolint et al., 2004). We therefore examined how activated
LNCD8+ T cells modulate expression of CXCR3, which regulates
tissue trafficking (Bonecchi et al., 1998; Sallusto et al., 1998), and
CD69, which prevents tissue egress via interactions with S1PR
(Matloubian et al., 2004). Dividing LN CD8+ T cells upregulated
CXCR3 within 1 or 2 cell divisions after stimulation with HIV pep-
tides or SEB (Figures 5D and S4H). Concomitantly, CD69 was
transiently upregulated after 2 or 3 cell divisions (Figures 5E
and S4H) and then lost. Finally, we examined whether activated
LN CD8+ T cells modulate expression of CXCR5. No consistent
patterns of CXCR5 upregulation were detected for LN CD8+
T cells dividing in response to either HIV peptides or SEB (Fig-
ure S4I). Recent studies have demonstrated that transforming
growth factor b (TGF-b) could selectively induce CXCR5 expres-
sion on rhesus macaque LN CD8+ T cells (Mylvaganam et al.,
2017). We therefore assessed whether human tonsil CD8+
T cells similarly upregulated CXCR5 in response to TGF-b and/
or interleukin-12 (IL-12). We did not find that these two cytokines,
either alone or in combination, selectively induced CXCR5
expression on dividing cells, but they did each appear to main-
tain CXCR5 expression on CD8+ T cells compared to cells
dividing in the absence of these cytokines (Figure S4J).
Together, these results suggest that HIV-specific CD8+ T cells
activated in situ would be prompted to leave the LN rather than
traffic to LN follicles.
DISCUSSION
The sequestration of CD4+ Tfh cells into B cell follicles during
chronic infection represents one mechanism by which CD8+
T cells are unable to eliminate HIV-infected CD4+ T cell reservoirs
(Lindqvist et al., 2012; Perreau et al., 2013; Petrovas et al., 2012).
Here, we show that CD8+ T cells from human LNs do not possess
attributes associated with peripheral cytolytic CD8+ T cell func-
tion. In HIV infection, LN HIV-specific CD8+ T cells acquire
some hallmarks of cytolytic function but retain characteristics
that likely limit in vivo cytolytic activity, including low perforin
expression, reduced cytolytic protein co-expression, alternateCell Reports 21, 3458–3470, December 19, 2017 3465
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Figure 5. Proliferating CD8+ T Cells Do Not Fully Acquire Cytolytic Properties and Express Marker Patterns Associated with Tissue Egress
in LNs
(A–E) Assessment of perforin (A), gzmB (B), T-bet (C), CXCR3 (D), and CD69 (E) expression in CFSE-labeled total CD8+ T cells in LNMCs after 5 days of stimulation
with HIV clade B consensus Gag and Nef peptides (n = 5 HIV, HIV+; n = 4 HIV+ ART). Flow plots (left) show representative data from an ART-treated HIV+
individual, and graphs (right) show protein expression frequency versus cell division (0–8 on the x axis). The gating strategy is shown in Figure S4F. D0 refers to
prestimulation protein expression levels. Open blue circle, HIV; open black square, HIV+ therapy naive; open red triangle, HIV+ on ART. Ranges shown on plots
represent mean ± SEM.transcriptional regulation of effector function, and activation-
induced tissue trafficking patterns.
Studies of HIV immunopathogenesis have associated CD8+
T cell functionality (Almeida et al., 2007; Betts et al., 2006), spec-
ificity (Goulder et al., 1997; Migueles et al., 2000), proliferative
capacity (McKinnon et al., 2012; Migueles et al., 2002, 2009),
memory phenotype (Addo et al., 2007; Almeida et al., 2007; Ja-
gannathan et al., 2009), and cytolytic potential (Hersperger et al.,
2010; Migueles et al., 2002, 2008; Sa´ez-Cirio´n et al., 2007) as
correlates of protection from disease progression. However, it
is unclear whether these peripheral blood CD8+ T cell correlates
apply to HIV-infected LN. In line with previous studies (Altfeld
et al., 2002; Connick et al., 2007; Oxenius et al., 2001), we did
not find substantial differences in the frequency of HIV-specific
CD8+ T cells between LNs and peripheral blood. However, pro-
found qualitative differences were apparent between these com-3466 Cell Reports 21, 3458–3470, December 19, 2017partments. While LN HIV-specific CD8+ T cells could individually
express perforin, gzmB, and/or degranulate (data not shown) in
response to stimulation, only a fraction displayed all three attri-
butes, which are required in unison for cytolytic activity. Limited
cytolytic potential is further compounded by restricted follicular
access, as only a portion of LN memory and HIV-specific CD8+
T cells express CXCR5. In concordance with this, we found
that CD8+ T cells from lymphoid tissue, regardless of whether
they express CXCR5, were very limited in their ability to kill target
cells. Accordingly, strategies designed to eliminate viral reser-
voirs in lymphoid tissue by re-invigorating HIV-specific CD8+
T cell cytolytic activity in ART-treated individuals must contend
with additional factors beyond the follicular localization of HIV-
infected CD4+ T cells.
The transcription factors T-bet (Sullivan et al., 2003; Szabo
et al., 2000) and eomes (Cruz-Guilloty et al., 2009; Pearce
et al., 2003; Pipkin and Rao, 2009) have been highly associated
with cytolytic function in CD8+ T cells. The finding that T-bet
was not associated with cytolytic molecule expression in LN
CD8+ T cells was unexpected, especially because peripheral
blood CD8+ T cells from the same individuals demonstrated
coordinate expression of T-bet and perforin. Moreover, T-bet
expression was substantially lower in LN CD8+ T cells than in pe-
ripheral blood CD8+ T cells and did not associate with effector-
like memory CD8+ T cells. Although eomes induces effector
CD8+ T cell differentiation in mice (Pipkin et al., 2010), we found
no association with cytolytic protein expression in human blood
or LNs. However, we did find more eomes-expressing CD8+
T cells in HIV-infected compared to uninfected LNs. These
data suggest that transcriptional control of CD8+ T cell cytolytic
function is regulated differently in LNs and blood or perhaps that
temporal regulation prevents the acquisition of cytolytic function
in LNs. In line with this, activated LN CD8+ T cells were able to
express perforin, gzmB, and T-bet after cell division, but this
gain of function was coupled with a concomitant modulation of
trafficking markers to promote LN egress. These findings are
consistent with mouse models (Wolint et al., 2004) and predict-
able based on canonical T cell responses to disease (Masopust
and Schenkel, 2013). Together, these findings indicate that we
have yet to identify all of the mechanisms that control cytolytic
protein expression and effector function in lymphoid tissue.
Recent murine data have demonstrated that follicular CXCR5+
CD8+ T cells are a central component of antiviral immunity (He
et al., 2016; Im et al., 2016; Leong et al., 2016). However, it is un-
clear whether CXCR5+ CD8+ T cells in these studies represent
bona fide cytolytic CD8+ T cells. Here, we applied an extensive
assessment of cytolytic killing through measurement of the
simultaneous expression of perforin and gzmB, killing ability,
and the underlying transcriptional programming necessary for
cytolytic effector activity directly ex vivo from human lymphoid
tissue. In agreement with mouse studies, our results indeed
suggest that CXCR5+ CD8+ T cells in lymphoid tissue play a
role in the immune response against HIV. However, we also
found that the strong inverse correlation between peripheral
viremia and the frequency of CXCR5+ CD8+ T cells in lymphoid
tissue is not dependent on cytolytic machinery. This finding links
conceptually with previous studies implicating non-cytolytic
mechanisms as key determinants of immune protection against
HIV and SIV (Blackbourn et al., 1996; Klatt et al., 2010; Wong
et al., 2010).
In summary, we have shown that CD8+ T cells with cytolytic
potential are relatively absent from human LNs. This finding sug-
gests the existence of a biological mechanism that limits CD8+
T cell-mediated immunopathology and enables antigen presen-
tation in a protected environment to facilitate the uninterrupted
development of adaptive immune responses. However, the
presence of an anatomically defined niche with immune privi-
leges also provides a safe haven for various intracellular patho-
gens such as HIV. Importantly, these concepts also extend
to mucosal tissues, as similar observations of limited cytolytic
ability, low perforin expression, and low T-bet expression by
mucosal tissue CD8+ T cells are apparent in both uninfected
and chronically HIV-infected subjects (Kiniry et al., 2017; Quigley
et al., 2006; Shacklett et al., 2004). Novel therapeutic strategieswill therefore be required to counteract this natural lack of im-
mune surveillance in the effort to purge and eradicate HIV reser-
voirs from both lymphoid and nonlymphoid tissues.
EXPERIMENTAL PROCEDURES
Study Groups
Peripheral blood collection and/or LN biopsies were performed in 80 individ-
uals classified as HIV (n = 40), HIV+ chronic untreated (n = 25), or HIV+ on
ART (n = 15). Subject grouping, age, sex, sample collection, and clinical pa-
rameters are summarized in Table 1. All enrolled participants gave written
informed consent as per protocols approved by the INER-CIENI ethics com-
mittee and the Federal Commission for the Protection against Sanitary Risk
(COFEPRIS), the institutional review boards of the University of Pennsylvania
and Case Western Reserve University, or the University General Hospital of
Heraklion, Crete, Greece. Sample sizes were based on the availability of bio-
logical samples rather than a prespecified effect size. Exclusion criteria for
samples were solely based on cell viability >70%.
Flow Cytometry
PBMC and LNMC stimulations were performed from cryopreserved material
as described previously (Hersperger et al., 2010; Makedonas et al., 2010).
Cells were incubated at a concentration of 1–23 106 cells/mL in completeme-
dium (1 mL per condition) in the presence of costimulatory antibodies (3 mL/mL
BD FastImmune a-CD28/CD49d, clones L293 and L25, BD Biosciences) and
a-CD107a PE-Cy5 (clone H4A3, eBioscience) to measure degranulation for
6 hr total at 37C in a 5% CO2 atmosphere with peptide pools representing
HIV-1 Gag or Env gp120 (2 mg/mL, clade B, NIH AIDSReagent Program) or epi-
topes from cytomegalovirus, Epstein-Barr virus, and influenza virus (1 mg/mL
each, NIH AIDS Reagent Program; Kern et al., 1999; Munz, 2005; Wills et al.,
1996). As a positive control, cells were stimulated with 1 mg/mL SEB (Sigma).
After 1 hr, cultures were supplemented with 1 mg/mL brefeldin A (Sigma) and
0.7 mL/mL BD GolgiStop (BD Biosciences).
Proliferation assays were performed using PBMCs and LNMCs labeled with
CellTrace CFSE (Molecular Probes, Invitrogen). Cells were stimulated with
peptide pools spanning HIV-1 Gag and Nef (1 mg/mL each, clade B consensus,
NIH AIDS Reagent Program, Division of AIDS [DAIDS], National Institute of
Allergy and Infectious Diseases [NIAID], NIH) or 1 mg/ml SEB (Sigma) for
5 days in the presence of recombinant human IL-2 (100U/mL) and plate-bound
a-CD28/CD49d (BD Biosciences).
All flow cytometry immunostaining was performed as described previously
(Hersperger et al., 2010; Makedonas et al., 2010). The antibodies andMHC tet-
ramers used are described in Supplemental Experimental Procedures. Briefly,
cells werewashed in PBS and, in some cases, incubated with a-CCR7 at 37C.
Cells were labeled with the amine reactive dye LIVE/DEAD Fixable Aqua (Mo-
lecular Probes, Invitrogen) prior to incubation with antibodies against surface
proteins. Intracellular proteins and cytokines were labeled after subsequent
fixation/permeabilization with BD Cytofix/Cytoperm (BD Biosciences). For
tetramer analyses, cells were incubated with tetramers for 10 min before
pre-stain. All MHC class I tetramers were produced as described previously
(Price et al., 2005). Cells were fixed in paraformaldehyde before analysis.
Cytometric Analyses
For all flow cytometric assays, at least 500,000 events were acquired using a
modified LSR-II equipped with FACSDIVA software (BD Biosciences). Data
were analyzed with FlowJo software (version 9.8.5, Tree Star). The following
gating scheme was used to identify CD8+ T cells of interest: a time gate to
ensure sample flow rate was consistent, singlets, lymphocytes, viable (LIVE/
DEAD Aqua), CD14, CD16, CD19, CD3+, CD4, CD8+. Cell divisions
within the proliferation experiments were determined automatically using the
FlowJo cell proliferation platform, assuming the default maximal cell division
number of 8. Cell division ‘‘bins’’ were then applied to the CFSE dilution of
each individual marker of interest in order to define modulation of specific
markers with respect to cell division history.
Cell ACCENSE (automatic classification of cellular expression by nonlinear
stochastic embedding) analyses were performed to visualize phenotypicCell Reports 21, 3458–3470, December 19, 2017 3467
relationships within multivariate data obtained from resting cells from 14 indi-
viduals (4–5 from each group). This program combines nonlinear dimension-
ality reduction with density-based partitioning, outputting unbiased protein
expression data from all measured parameters as a two-dimensional plot
(Shekhar et al., 2014; van der Maaten, 2013). PBMC and LNMC memory
CD8+ T cell or LNMC CXCR5+/CXCR5 memory CD8+ T cell data were ex-
ported from FlowJo as FCS files. Cell ACCENSE was used to perform a
Barnes-Hut-SNE dimensional reduction analysis on a total of 800,000 down-
sampled events to generate two-dimensional tSNE plots.
Imaging Analysis
Paraffin-embedded sections (6–10 mm) were deparaffinized, and antigen
retrieval was performed using a decloaking chamber (125C, 30 s, Biocare
Medical) with Borg Decloaker buffer (Biocare Medical). Tissues were blocked
(0.1 M Tris, 0.3% Triton X-100, 1% BSA) for 1 hr at room temperature (RT),
stained with titrated amounts of nonconjugated antibodies (a-granzyme B,
a-CD8) overnight at 4C, washed with PBS (3 3 20 minutes), and stained
with the appropriate secondary antibodies for 2 hr at RT. After a second block-
ing step with a 1:1 mixture of normal mouse serum (1 hr at RT), tissues were
stained with titrated amounts of directly conjugated antibodies (a-CD20,
a-perforin). JoJo staining was performed after a final wash step, and the slides
were mounted with Fluoromount G (SouthernBiotech). Images were collected
on a Leica SP8 confocal microscope using a 203 0.75 numerical aperture (NA)
or 403 1.30 NA objective with a 1.53 optical zoom at a density of 1,024 3
1,024 pixels. Additional images were captured using a 633 1.40 NA objective.
Fluorophore spillover was corrected by imaging single-stained tissues and
creating a compensation matrix via the Leica LAS-AF Channel Dye Separation
module (Leica Microsystems). Compensated images were analyzed with
Imaris software (Bitplane Scientific).
Statistical Analyses
Statistical analyses were performed with Prism software (version 5.0a,
GraphPad). Non-parametric tests were used to determine significance
between groups using the Mann-Whitney two-tailed test (for two groups),
the Kruskal-Wallis test with Dunn’s post-test (for three or more groups), or
the Wilcoxon matched-pairs two-tailed test (for paired samples) (*p < 0.05;
**p < 0.01; ***p < 0.001).
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